Medical device maker Abbott has received emergency authorization from the U.S. Food and Drug Administration (FDA) for its new molecular point-of-care covid-19 test, which will allow healthcare providers in a variety of different settings to obtain results almost immediately. The new test can deliver positive results…
from Gizmodo https://ift.tt/3aqXMTx
via
إرسال تعليق